EU okays increase in mRNA COVID-19 vaccines manufacturing capacity
Europe's medicines regulator said on Tuesday (Aug 24) it had approved additional manufacturing sites to increase production capacity of mRNA COVID-19 vaccines developed by Pfizer-BioNTech and Moderna for the region.
The recommendations do not require a decision by the European Commission and the sites can become operational immediately, the European Medicines Agency said.
BOOKMARK THIS: Our comprehensive coverage of the COVID-19 pandemic and its developments
Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus pandemic: https://cna.asia/telegram